Biocon’s subsidiary, Syngene International, announced that it has entered into a contract research agreement with the Novartis Institutes for Biomedical Research Inc to carry out research projects to support new drug discovery and development.
The contract research agreement was signed recently after a senior contingent from Cambridge, United States, visited Syngene in Bangalore last month.